585 related articles for article (PubMed ID: 26607911)
21. Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson's disease- emphasizing the role of mitochondrial biogenesis.
Peshattiwar V; Muke S; Kaikini A; Bagle S; Dighe V; Sathaye S
Brain Res Bull; 2020 Jul; 160():150-161. PubMed ID: 32147532
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats.
Madathil KS; Karuppagounder SS; Haobam R; Varghese M; Rajamma U; Mohanakumar KP
Neurochem Int; 2013 Apr; 62(5):674-83. PubMed ID: 23353925
[TBL] [Abstract][Full Text] [Related]
23. SMER28 Attenuates Dopaminergic Toxicity Mediated by 6-Hydroxydopamine in the Rats via Modulating Oxidative Burdens and Autophagy-Related Parameters.
Darabi S; Noori-Zadeh A; Rajaei F; Abbaszadeh HA; Bakhtiyari S; Roozbahany NA
Neurochem Res; 2018 Dec; 43(12):2313-2323. PubMed ID: 30288644
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
[TBL] [Abstract][Full Text] [Related]
25. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; Mf NM; Ojha SK; Adem A; Jalal FY
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081327
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
[TBL] [Abstract][Full Text] [Related]
27. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
Rahimmi A; Khosrobakhsh F; Izadpanah E; Moloudi MR; Hassanzadeh K
Brain Res Bull; 2015 Apr; 113():34-40. PubMed ID: 25732239
[TBL] [Abstract][Full Text] [Related]
28. Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.
Michel HE; Tadros MG; Esmat A; Khalifa AE; Abdel-Tawab AM
Mol Neurobiol; 2017 Sep; 54(7):4866-4878. PubMed ID: 27514753
[TBL] [Abstract][Full Text] [Related]
29. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapy.
Zaitone SA; Ahmed E; Elsherbiny NM; Mehanna ET; El-Kherbetawy MK; ElSayed MH; Alshareef DM; Moustafa YM
Pharmacol Rep; 2019 Feb; 71(1):32-41. PubMed ID: 30368226
[TBL] [Abstract][Full Text] [Related]
30. Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis.
Liu YL; Hsu CC; Huang HJ; Chang CJ; Sun SH; Lin AM
Mol Neurobiol; 2020 Jan; 57(1):96-104. PubMed ID: 31832973
[TBL] [Abstract][Full Text] [Related]
31. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
32. Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease.
Zaminelli T; Gradowski RW; Bassani TB; Barbiero JK; Santiago RM; Maria-Ferreira D; Baggio CH; Vital MA
Neurotox Res; 2014 Nov; 26(4):351-62. PubMed ID: 24740429
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease.
Javed H; Azimullah S; Haque ME; Ojha SK
Front Neurosci; 2016; 10():321. PubMed ID: 27531971
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
Sharma S; Kumar P; Deshmukh R
Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.
Khadrawy YA; Salem AM; El-Shamy KA; Ahmed EK; Fadl NN; Hosny EN
J Diet Suppl; 2017 Sep; 14(5):553-572. PubMed ID: 28301304
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
Wu L; Tian YY; Shi JP; Xie W; Shi JQ; Lu J; Zhang YD
Neurosci Lett; 2013 Aug; 548():50-5. PubMed ID: 23774475
[TBL] [Abstract][Full Text] [Related]
39. Tannic Acid Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Inflammation, Oxidative Stress, Apoptosis, and Glutamate Toxicity in Rats.
Azimullah S; Meeran MFN; Ayoob K; Arunachalam S; Ojha S; Beiram R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373023
[TBL] [Abstract][Full Text] [Related]
40. Purified anacardic acids exert multiple neuroprotective effects in pesticide model of Parkinson's disease: in vivo and in silico analysis.
Augusto RL; Mendonça IP; de Albuquerque Rego GN; Pereira DD; da Penha Gonçalves LV; Dos Santos ML; de Souza RF; Moreno GMM; Cardoso PRG; de Souza Andrade D; da Silva-Júnior JC; Pereira MC; Peixoto CA; Medeiros-Linard CFB; de Souza IA; Andrade-da-Costa BLDS
IUBMB Life; 2020 Aug; 72(8):1765-1779. PubMed ID: 32449271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
